PD-L1 Inhibition With Avelumab for Metastatic Merkel Cell Carcinoma

Expert Review of Clinical Pharmacology - United Kingdom
doi 10.1080/17512433.2018.1445966
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited